Corporate Industry Symposia

Thursday, 22 October 2020

Amgen-sponsored corporate satellite symposium at ECTS 2020 

Time: 13.45–15.15

Live Stream 1

 

 

13:45 – 15:15

13:45 – 13:50

13:50 – 14:15

14:15 – 14:40

14:40 -15:05

15:05 – 15:15

Satellite Symposium Amgen (Europe) GmbH : Optimising Bone Health: recognising and treating a wide patient spectrum – Chairs : Roland Chapurlat (France) & Richard Eastell (UK)

Welcome and Introduction – Roland Chapurlat (France) & Richard Eastell (UK)

What is the optimal long-term treatment sequence for osteoporosis patient ? – Richard Eastell (UK)

Bone sweet bone; how diabetes mellitus impair bone quality – Lorenz Hofbauer (Germany)

Clinical updates in osteogenesis imperfecta – Jorg Oliver Semler (Germany)

Q&A and close – Richard Eastell (UK)

Friday, 23 October 2020

Ipsen Pharma -sponsored corporate satellite symposium at ECTS 2020 

Time: 13.45–15.15

Live Stream 1

 

 

13:45 – 15:15

13:45 – 14:00

14:00 – 14:20

14:20 – 14:40

 

14:40 – 15:00

 15:00 – 15:15

Satellite Symposium Ipsen Pharma : What can we learn from the FOP community ? – Chairs : Valerie Cormier-Daire (France)

Chairperson’s welcome and introduction – Valerie Cormier-Daire (France)

Ten things we have learned about FOP in the last 30(0) years – Richard Keen (UK)

Understanding the natural history and other special considerations for clinical trials in FOP – Heike Hoyer-Kuhn (Germany)

 Patient-driven data in rare bone diseases : A concrete example from the FOP Registry – Sammi Kile (United States)

 Panel discussions and conclusions – Valerie Cormier-Daire (FOP)

Saturday, 24 October 2020

UCB-sponsored satellite symposium at ECTS 2020

Time: 13:45 – 15:15 

Live Stream 1

13:45 – 15:15

13:45 – 13:50

13:50 – 14:10

 

14:10 – 14:30

14:30 – 14:50

14:50 – 15:10

15:10 – 15:15

Building stronger bones: a new approach to fracture management in severe osteoporosis – Chairs : Thierry Thomas (France)

Welcome and introduction – Thierry Thomas (France)

Improving bone strength in postmenopausal women with severe osteoporosis: An opportunity to take a different approach ? – John Carey (Ireland)

 Mechanisms and effects of therapeutic interventions on bone microstructure and strength – Roland Baron (United States)

A new treatment option for postmenopausal women with severe osteoporosis – Bente Langdahl (Denmark)

 Panel discussion

Conclusion and closing remarks – Thierry Thomas (France)

 Corporate Mini Symposia

Friday, 23 October 2020

Gedeon Richter-sponsored mini corporate symposium at ECTS 2020

Time: 19:00 – 20:00

Live Stream 1

 

19:00 – 20:00

Mini Corporate Symposium Gedeon Richter : Bone Anabolic Treatment – The past, the present and the future – Chairs : Prof. Peyman Hadji

How to individualise treatment – an interactive case presentation – Peyman Hadji (Germany)

Friday, 23 October 2020

Inozyme Pharma-sponsored mini corporate symposium at ECTS 2020

Time: 19:00 – 20:00

Live Stream 2

 

 

19:00 – 20:00

19:00-19:10

19:10 – 19:20

19:20 – 19:35

19:35 – 19:50

19:50 – 20:00

 

Mini Corporate Symposium Inozyme Pharma, Inc: The Natural History of ENPP1 Deficiency: A Clinical Spectrum from GACI to ARHR2 – Chair: Pedro Huertas (United States)

Welcome

The key role of PPi in driving diseases of ectopic mineralization – Pedro Huertas (United States)

A Natural History of ENPP1 deficiency – Frank Rutsch (Germany)

GACI & ARHR2: Lessons learnt from a clinical case – Zulf Mughal (United Kingdom)

Discussion Time

More information soon…